USA | Reagan-Udall Report Calls for Greater Regulatory Agility and New Evidence Approaches in Rare Disease Development
Please login to view this page.
- USA | FDA Publishes ICH M14 Guidance on Non-Interventional Studies Using Real-World Data & Withdraws 2013 Guidance Gallery
USA | FDA Publishes ICH M14 Guidance on Non-Interventional Studies Using Real-World Data & Withdraws 2013 Guidance
2026, March 2026, Members-Only, RWD to Support Reg Decisions, Secondary Use of Existing Data, Significant Update, USA
USA | FDA Publishes ICH M14 Guidance on Non-Interventional Studies Using Real-World Data & Withdraws 2013 Guidance
Please login to view this page.
- USA | FDA Issues Draft Guidance on Bayesian Methodology — Implications for Use of Real-World Data as External Information Gallery
USA | FDA Issues Draft Guidance on Bayesian Methodology — Implications for Use of Real-World Data as External Information
2026, January 2026, Members-Only, Minor Update, RWD to Support Reg Decisions, Secondary Use of Existing Data, USA
USA | FDA Issues Draft Guidance on Bayesian Methodology — Implications for Use of Real-World Data as External Information
Please login to view this page.
- USA | FDA Approves Paediatric Rare Disease Treatment Supported by Real-World Evidence Gallery
USA | FDA Approves Paediatric Rare Disease Treatment Supported by Real-World Evidence
2026, January 2026, Members-Only, Minor Update, Rare Diseases, RWD to Support Reg Decisions, Secondary Use of Existing Data, USA
USA | FDA Approves Paediatric Rare Disease Treatment Supported by Real-World Evidence
Please login to view this page.
USA | FDA Draft Guidance on Sex Differences Reinforces Expectations for Non-Interventional Studies
Please login to view this page.
- USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics Gallery
USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics
2025, December 2025, Members-Only, Moderate Update, RWD to Support Reg Decisions, Secondary Use of Existing Data, USA
USA | FDA Removes Requirement for Identifiable Patient Data in Certain Medical Device RWE Submissions – Signals Potential Extension to Drugs and Biologics
Please login to view this page.
USA | FDA Issues Updated Final Guidance on Use of Real-World Evidence for Medical Devices
Please login to view this page.
USA | E-Prescribing and Interoperability Rules Strengthen Foundations for Real-World Evidence
Please login to view this page.
USA | FDA’s CDER Reports RWE Submission Trends
Please login to view this page.










